Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

7.2K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glenzocimab Efficacy and Safety Added to Intravenous Thrombolysis With or Without Mechanical Thrombectomy in Patients With Acute Ischemic Stroke-ACTISAVE: A Prospective, Randomized, Double-Blind Study.

Stroke·2026
Same author

Efficacy and Safety of NFL-101 as a Smoking Cessation Therapy: A Randomized Phase II Clinical Trial CESTO2.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco·2025
Same author

Targeting GPVI with glenzocimab in COVID-19 patients: Results from a randomized clinical trial.

PloS one·2024
Same author

Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO<sup>®</sup> in Healthy Adults.

Neurology and therapy·2024
Same author

Safety and efficacy of platelet glycoprotein VI inhibition in acute ischaemic stroke (ACTIMIS): a randomised, double-blind, placebo-controlled, phase 1b/2a trial.

The Lancet. Neurology·2024
Same author

Controlled human infection trials: Legitimacy and conditions of implementation in France.

Therapie·2023
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Related Experiment Video

Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K

[Not Available].

Catherine Lassale1, Claire Sibenaler1, Jehan-Michel Béhier2

  • 1Les Entreprises du Médicament (Leem), Paris, France.

Therapie
|July 10, 2016
PubMed
Summary
This summary is machine-generated.

France is a top European country for international clinical trials, excelling in patient recruitment and streamlined administrative processes. Its strong performance in early-phase studies, oncology, and infectious diseases enhances its appeal for global research.

Keywords:
Francecompetitivenesscompétitivitéentreprises du médicamentinternational clinical researchpharmaceutical companiesrecherche clinique internationale

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Area of Science:

  • Clinical research methodology
  • Pharmaceutical industry analysis
  • International health policy

Context:

  • France's position in international clinical trials is assessed biennially via surveys of pharmaceutical companies.
  • The study analyzes data from 385 international Phase II and III clinical studies conducted in 2006/2007.
  • Nineteen companies, representing 61.9% of the French market, participated.

Purpose:

  • To evaluate the attractiveness of France as a location for conducting international clinical trials.
  • To identify factors contributing to France's performance in global clinical research.
  • To benchmark France's recruitment capabilities against other European nations.

Summary:

  • France ranks second in Europe for patient recruitment (400 patients/million inhabitants), behind Scandinavia.
  • Streamlined administrative processes and reduced hospital contract timelines have been implemented since 2006.
  • French regulatory authorities (Afssaps and CPP) now approve protocols within 60 days, aligning with European directives.
  • Strong performance in early-phase trials, oncology/hematology, and vaccines/anti-infectious studies bolsters France's research attractiveness.

Impact:

  • France demonstrates significant potential for international clinical trial conduct.
  • Improvements in regulatory efficiency and contract management enhance France's competitive edge.
  • The country's recruitment capacity and specialized research areas position it favorably for future global studies.